38siTo evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tract urothelial cancer (UTUC) and renal cancer) in patients referred to secondary care with haematuria, adjusted for established patient risk markers and geographical variation.openopenKhadhouri, Sinan; Gallagher, Kevin M; MacKenzie, Kenneth R; Shah, Taimur T; Gao, Chuanyu; Moore, Sacha; Zimmermann, Eleanor F; Edison, Eric; Jefferies, Matthew; Nambiar, Arjun; Mannas, Miles P; Lee, Taeweon; Marra, Giancarlo; Lillaz, Beatrice; Gómez Rivas, Juan; Olivier, Jonathan; Assmus, Mark A; Uçar, Taha; Claps, Francesco; Boltri, Matteo; Burnhope, Tara; Nkwam, Nkwam; Tanasescu, George; Boxall, Nicholas E; Downey, Alison P; Lal, Asim Ahmed; Antón-Juanilla, Marta; Cl...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Funding Grants from Action Bladder Cancer UK, The Urology Foundation, The Rosetrees Trust were used ...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Funder: Action Bladder Cancer UKFunder: Rosetrees Trust; Id: http://dx.doi.org/10.13039/501100000833...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
ABSTRACT Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, ...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Funding Grants from Action Bladder Cancer UK, The Urology Foundation, The Rosetrees Trust were used ...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Funder: Action Bladder Cancer UKFunder: Rosetrees Trust; Id: http://dx.doi.org/10.13039/501100000833...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
ABSTRACT Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, ...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tra...
Funding Grants from Action Bladder Cancer UK, The Urology Foundation, The Rosetrees Trust were used ...